Literature DB >> 1737070

The chemical characterization of melanin contained in substantia nigra of human brain.

L Zecca1, C Mecacci, R Seraglia, E Parati.   

Abstract

The pigment of substantia nigra human brain has been extracted by a mild procedure consisting of washes with phosphate buffer, methanol and incubation with SDS-proteinase. Pyrolysis gas chromatography mass spectrometry, infrared spectrometry, termogravimetric analysis and elemental analysis were the techniques used for the chemical characterization. An indole moiety bound to a sulfur containing amino acid and to palmitic acid were the main aspects found in the structure. The presence of a 7% inorganic component was observed. This probably contains Fe, Cu, Zn and Cr which are also relevant, for the formation and the role of melanin in substantia nigra neurons. The fatty acid moiety is chemically bound to the indole structure as it was not eliminated by repeated methanol washing. The same situation occurs for the sulfur containing group. Considering these data and the most abundant molecules present in substantia nigra the precursor of neuromelanin seems to be a cysteinyl-catechol, to which is then bound a palmityl group.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737070     DOI: 10.1016/0925-4439(92)90144-c

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.

Authors:  William D Bush; Jacob Garguilo; Fabio A Zucca; Alberto Albertini; Luigi Zecca; Glenn S Edwards; Robert J Nemanich; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

3.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

Review 4.  Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.

Authors:  L Zecca; D Tampellini; M Gerlach; P Riederer; R G Fariello; D Sulzer
Journal:  Mol Pathol       Date:  2001-12

5.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

6.  X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues.

Authors:  A J Kropf; B A Bunker; M Eisner; S C Moss; L Zecca; A Stroppolo; P R Crippa
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

7.  GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.

Authors:  Anna Dzierzega-Lecznar; Slawomir Kurkiewicz; Krystyna Stepien; Ewa Chodurek; Tadeusz Wilczok; Thomas Arzberger; Peter Riederer; Manfred Gerlach
Journal:  J Am Soc Mass Spectrom       Date:  2004-06       Impact factor: 3.109

8.  An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs.

Authors:  Pier Raimondo Crippa; Melvin Eisner; Silvia Morante; Francesco Stellato; Flavio C Vicentin; Luigi Zecca
Journal:  Eur Biophys J       Date:  2009-05-27       Impact factor: 1.733

Review 9.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 10.  Discovering novel brain lipids by liquid chromatography/tandem mass spectrometry.

Authors:  Ziqiang Guan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-11       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.